The DELTA HEALTH GROUP is a multi-functional, global healthcare enterprise focused on providing a comprehensive portfolio of innovative clinical drug development expertise, a worldwide network of dedicated clinical trial investigative sites, international telemedicine, global destination medical services and an innovative medical products division.
Initially starting with the operation of a group of successful clinical trial investigative sites at the time of embarking on its journey more than two decades back, the DELTA HEALTH GROUP has progressively evolved and diversified its capabilities in the clinical drug development and healthcare arena.
We have been assisting partners in the healthcare sector optimize and develop reformulated drug products, new chemical entities, biologics and medical devices that aim to offer advanced therapies and an improvement to available patient care.
With a time-tested proven track record spanning over 20 years, the highly talented and experienced specialists of our team have lead full clinical development programs that have resulted in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA), Health Canada and other international agencies.
We are also one of the privileged few in the healthcare industry having extensive experience with direct in-person interaction and successful working collaboration with the US FDA and Health Canada.
The DELTA HEALTH GROUP has continued its expansion in the international arena and now operates clinical trial investigative sites specialized in conducting Phase 2 and Phase 3 drug development clinical trials.
Our international healthcare portfolio includes telemedicine expertise with world-class medical specialists and global destination medical services.
Strongly supporting innovation in healthcare, we have also diversified our capabilities into providing novel medical products to complement our motto "Global Healthcare".